Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Deferred income tax provision (benefit) — Total by Year
Deferred income tax provision (benefit) — Total ($M) ($M)
Vertex Pharmaceuticals Deferred income tax provision (benefit) — Total: -$511M in FY2025, up 46.4% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Income Taxes).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred income tax provision (benefit) — Total ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -511 | +46.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | -349 | -35.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | -537 | +94.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | -276 | +78.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | -155 | -155.8% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 277 | +65.7% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 167 | -111.1% | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | -1,512 | +1,086.0% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | -128 | -854.4% | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 16.9 | +5,533.3% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 0.30 | – | Form 10-K (filed 2018-02-15) ↗ |
Breakdown
What makes up deferred income tax provision (benefit) — Total
Cite this data
StockData. (2026). Vertex Pharmaceuticals Deferred income tax provision (benefit) — Total ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/tax-def-tot
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.